Stay updated on NSCLC Progressed Anti-PD-1 Clinical Trial
Sign up to get notified when there's something new on the NSCLC Progressed Anti-PD-1 Clinical Trial page.

Latest updates to the NSCLC Progressed Anti-PD-1 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision labels updated to v3.4.2 with v3.4.1 removed, and there are no changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check38 days agoChange DetectedDifference0.1%

- Check52 days agoChange DetectedThe page now displays a glossary and new results metadata (Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted), while removing a few estimated data fields and the previous revision label.SummaryDifference0.2%

- Check59 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.0%

- Check88 days agoChange DetectedAdded a consolidated Locations section listing California, District of Columbia, Illinois, Maryland, Massachusetts, Missouri, New York, Pennsylvania, Tennessee, Texas, Virginia, Alberta, Ontario, and Quebec; removed the previous per-state and per-province location subsections.SummaryDifference0.9%

Stay in the know with updates to NSCLC Progressed Anti-PD-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NSCLC Progressed Anti-PD-1 Clinical Trial page.